Allostatic load is associated with symptoms in chronic fatigue syndrome patients
Abstract
Objectives: To further explore the relationship between chronic fatigue syndrome (CFS) and allostatic load (AL), we conducted a computational analysis involving 43 patients with CFS and 60 nonfatigued, healthy controls (NF) enrolled in a population-based case–control study in Wichita (KS, USA). We used traditional biostatistical methods to measure the association of high AL to standardized measures of physical and mental functioning, disability, fatigue and general symptom severity. We also used nonlinear regression technology embedded in machine learning algorithms to learn equations predicting various CFS symptoms based on the individual components of the allostatic load index (ALI). Methods: An ALI was computed for all study participants using available laboratory and clinical data on metabolic, cardiovascular and hypothalamic–pituitary–adrenal (HPA) axis factors. Physical and mental functioning/impairment was measured using the Medical Outcomes Study 36-item Short Form Health Survey (SF-36); current fatigue was measured using the 20-item multidimensional fatigue inventory (MFI); frequency and intensity of symptoms was measured using the 19-item symptom inventory (SI). Genetic programming, a nonlinear regression technique, was used to learn an ensemble of different predictive equations rather just than a single one. Statistical analysis was based on the calculation of the percentage of equations in the ensemble that utilized each input variable, producing a measure of the ‘utility’ of the variable for the predictive problem at hand. Traditional biostatistics methods include the median and Wilcoxon tests for comparing the median levels of subscale scores obtained on the SF-36, the MFI and the SI summary score. Results: Among CFS patients, but not controls, a high level of AL was significantly associated with lower median values (indicating worse health) of bodily pain, physical functioning and general symptom frequency/intensity. Using genetic programming, the ALI was determined to be a better predictor of these three health measures than any subcombination of ALI components among cases, but not controls.
Bibliography
- 1 McEwen BS, Stellar E: Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med.153, 2093–2101 (1993).
- 2 McEwen BS, Seeman, T: Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann. NY Acad. Sci.896, 30–47 (1999).
- 3 Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE: Allostatic load is a predictor of functional decline. MacArthur studies of successful aging. J. Clin. Epidemiol.55, 696–710 (2002)
- 4 Seeman TE, McEwen BS, Rowe JW, Singer BH: Allostatic load as a marker of cumulative biological risk: MacArthur Studies of Successful Aging. Proc. Natl Acad. Sci. USA98, 4770–4775 (2001).
- 5 Maloney EM, Gurbaxani BM, Jones JF, Coelho LdS, Pennachin C, Goertzel BN: Chronic fatigue syndrome and high allostatic load. Pharmacogenomics7(3), 467–473 (2006).
- 6 Reeves WC, Wagner D, Nisenbaum R et al.: Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med.3, 19 (2005).
- 7 Vernon SD, Reeves WC: The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogemomics7(3), 345–354 (2006).
- 8 Koza JR: Genetic Programming. MIT Press, Cambridge, MA, USA (1998).
- 9 Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A and the International Chronic Fatigue Syndrome Study Group: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med.1211, 953–959 (1994).
- 10 Jones JF, Nicholson A, Nisenbaum R et al.: Orthostatic instability in a population-based study of chronic fatigue syndrome. Am. J. Med.118(12), 1415 (2005).
- 11 Ware JE, Kosinski M: SF-36 Physical & Mental Health Summary Scale: A Manual for Users of Version 1. Second Edition. QualityMetric Inc., Lincoln, RI, USA, 5–8 (2001).
- 12 Bergman S, Jacobsson LTH, Herrström P, Petersson IF: Health status as measured by SF-36 reflects changes and predicits outcome of chronic musculoskeletal pain: a 3-year follow up study in the general population. Pain108, 115–223 (2004)
- 13 Lieberman J, Bell DS: Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. Am. J. Med.95, 407–412 (1993).
- 14 Gurbaxani BM, Jones JF, Goertzel BN, Maloney EM: Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndrome. Pharmacogenomics7(3), 455–465 (2006).
- 15 Hellhammer J, Scholtz W, Stone AA, Pirke KM, Hellhammer D: Allostatic load, perceived stress, and health: a prospective study in two age groups. Ann. NY Acad. Sci.1032, 8–13 (2004).
